Why ARBs treatment in a crowded antihypertensive scenario?

Back

Open Access

Why ARBs treatment in a crowded antihypertensive scenario?

Session: ESC/ESH Guidelines on BP-lowering treatment: solutions for a new challenge

Topic: Treatment

Speaker: Professor J. Redon (Valencia, ES)

Sponsored by Menarini Group and Daiichi Sankyo

Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Josep Redon

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)

8 presentations

0 follower

3 more presentations in this session

Focus on hypertension guidelines.

Speaker: Professor M. Burnier (Lausanne, CH)

Access

Slides

Video

Early and fast BP control with patient-tailored treatment.

Speaker: Professor M. Volpe (Rome, IT)

Access

Slides

Video

Discussion - ESC/ESH Guidelines on BP-lowering treatment: solutions for a new challenge

Speaker: Professor G. Mancia (Milan, IT) Professor R. Schmieder (Erlangen, DE)

Access

Slides

Video

Access the full session

ESC/ESH Guidelines on BP-lowering treatment: solutions for a new challenge

Speakers: Professor J. Redon, Professor M. Burnier, Professor M. Volpe, Professor G. Mancia, Professor R. Schmieder

Access

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

Why ARBs treatment in a crowded antihypertensive scenario?

About the speaker

Professor Josep Redon

3 more presentations in this session

Focus on hypertension guidelines.

Early and fast BP control with patient-tailored treatment.

Discussion - ESC/ESH Guidelines on BP-lowering treatment: solutions for a new challenge

Access the full session

ESC/ESH Guidelines on BP-lowering treatment: solutions for a new challenge

About the event

ESC Congress 2018

ESC 365 is supported by